BIOA
BioAge Labs, Inc. · Healthcare · Market cap $369.9M
Insiders sold $1.7M net in the last 90 days ·2 sellers, 0 buyers· 3 of 3 sales under Rule 10b5-1 plans· latest Form 4 filed Jul 1, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$7.8M
reported sales (SEC code S)
Unique Insiders
4
in the rolling window
Latest filing
Jul 1, 2026
Barton Shane
BioAge Labs, Inc. (BIOA) has 13 SEC Form 4 filings (36 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Jul 1, 2026.
Inside the rolling window, 4 insiders at BioAge Labs, Inc. reported no open-market purchases and 10 open-market sales totaling $7.8M. The most active filer is Chief Medical Officer RUBIN PAUL D with 6 filings. Insiders have net sold $6.9M over the trailing 6 months. The most recent open-market filing is a sale of 42,350 shares by Principal Accounting Officer Barton Shane, dated Jun 29, 2026, worth $1.1M.
- Industry:Biotechnology
- CEO:Kristen Fortney
- Employees:62
- HQ:Emeryville, CA, US
- IPO:2024-09-26
| Source | |||||||
|---|---|---|---|---|---|---|---|
Barton ShaneFirst filing | Principal Accounting Officer | Sale | 42,350 | $1.1M | Jul 1 | -66.8% | SEC ↗ |
Barton ShaneFirst filing | Principal Accounting Officer | Sale | 20,216 | $509K | Jul 1 | -66.8% | SEC ↗ |
| Chief Medical Officer | Sale | 8,820 | $157K | Apr 3 | -54.0% | SEC ↗ | |
| Chief Medical Officer | Sale | 7,433 | $151K | Mar 3 | -60.6% | SEC ↗ | |
| Chief Medical Officer | Sale | 7,433 | $139K | Feb 3 | -59.5% | SEC ↗ | |
GOLDSTEIN DOV A MDFirst filing | Chief Financial Officer | Sale | 27,000 | $532K | Jan 15 | -62.5% | SEC ↗ |
Fortney KristenFirst filing | Chief Executive Officer | Sale | 233,107 | $4.2M | Jan 15 | -62.5% | SEC ↗ |
| Chief Medical Officer | Sale | 7,433 | $95K | Jan 6 | — | SEC ↗ | |
| Chief Medical Officer | Sale | 18,000 | $216K | Dec 11 | — | SEC ↗ | |
RUBIN PAUL DFirst filing | Chief Medical Officer | Sale | 68,897 | $702K | Dec 5 | — | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does BIOA have?
BioAge Labs, Inc. (BIOA) has 13 SEC Form 4 filings (36 transaction rows) in the rolling 365-day window, disclosed by 4 distinct insiders. Most recent filing: Jul 1, 2026.
When was the most recent SEC Form 4 filing for BIOA?
The most recent Form 4 filing for BIOA on Tracefour is dated Jul 1, 2026.
Who is the most active insider at BIOA?
The most active SEC Form 4 filer at BIOA in the rolling window is Chief Medical Officer RUBIN PAUL D, with 6 filings.
What is the net insider flow at BIOA over the last 6 months?
Over the trailing 180 days, insiders at BIOA have net sold $6.9M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at BIOA in the current window?
Inside the rolling window, insiders at BIOA bought $0 and sold $7.8M based on SEC Form 4 filings.
Can I get alerts for BIOA insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at BioAge Labs, Inc. (BIOA). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
BioAge Labs, Inc. is in the Healthcare sector.